QA: Altimmune Inc in us_pharma/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001326190_2012_Altimmune_Inc.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001326190, Altimmune Inc

  xvar xval
0 AssetsCurrent 19,613,006
1 IntangibleAssetsNetIncludingGoodwill 2,348,453
2 PropertyPlantAndEquipmentNet 788,666
3 remainder_Assets 53,384
4 LiabilitiesCurrent 4,615,342
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 2,336,361
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 14,311,079
9 ResearchAndDevelopmentExpense 21,219,853
10 remainder_Expenses 461,073
11 remainder_Revenues 24,266,274
12 remainder_NetIncome 7,928,158
13 remainder_ComprehensiveNetIncome -239,975
  yvar yval
0 Assets 22,803,509
1 Liabilities 6,951,703
2 Expenses 35,992,005
3 Revenues 24,266,274
4 StockholdersEquity 15,851,806
5 NetIncome -3,797,573
6 ComprehensiveNetIncome -3,917,560
7 BaseVar 49,090,812
8 EconomicCapitalRatiobeforeLimitedLiability 2.06
9 EconomicCapitalRatio 3.06

Edgar->Model Mapping

Feature Distribution